Modulation of apoptosis by adenosine in the central nervous system: a possible role for the A3 receptor. Pathophysiological significance and therapeutic implications for neurodegenerative disorders.
Abbracchio
M P
MP
Institute of Pharmacological Sciences, Milan, Italy. abbracch@isfunix.farma.unimi.it
Ceruti
S
S
Brambilla
R
R
Franceschi
C
C
Malorni
W
W
Jacobson
K A
KA
von Lubitz
D K
DK
Cattabeni
F
F
D000241:Adenosine / Q000494:pharmacology / Q000502:physiology*; D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D001253:Astrocytes / Q000166:cytology / Q000502:physiology; D001921:Brain / Q000166:cytology / Q000502:physiology* / Q000503:physiopathology; D002545:Brain Ischemia / Q000503:physiopathology; D006801:Humans; D009422:Nervous System Diseases / Q000503:physiopathology* / Q000628:therapy*; D018696:Neuroprotective Agents; D043684:Receptor, Adenosine A3; D018047:Receptors, Purinergic P1 / Q000502:physiology*; D009435:Synaptic Transmission / Q000502:physiology
D018696:Neuroprotective Agents; D043684:Receptor, Adenosine A3; D018047:Receptors, Purinergic P1; D000241:Adenosine